Hemagglutinin Glycoproteins, Influenza Virus
"Hemagglutinin Glycoproteins, Influenza Virus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Membrane glycoproteins from influenza viruses which are involved in hemagglutination, virus attachment, and envelope fusion. Fourteen distinct subtypes of HA glycoproteins and nine of NA glycoproteins have been identified from INFLUENZA A VIRUS; no subtypes have been identified for Influenza B or Influenza C viruses.
| Descriptor ID |
D019267
|
| MeSH Number(s) |
D12.776.964.970.880.345.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hemagglutinin Glycoproteins, Influenza Virus".
Below are MeSH descriptors whose meaning is more specific than "Hemagglutinin Glycoproteins, Influenza Virus".
This graph shows the total number of publications written about "Hemagglutinin Glycoproteins, Influenza Virus" by people in this website by year, and whether "Hemagglutinin Glycoproteins, Influenza Virus" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1998 | 1 | 1 | 2 |
| 1999 | 4 | 0 | 4 |
| 2000 | 0 | 2 | 2 |
| 2001 | 0 | 1 | 1 |
| 2002 | 2 | 1 | 3 |
| 2005 | 0 | 3 | 3 |
| 2006 | 1 | 1 | 2 |
| 2007 | 1 | 1 | 2 |
| 2008 | 2 | 0 | 2 |
| 2009 | 1 | 3 | 4 |
| 2010 | 0 | 1 | 1 |
| 2011 | 3 | 0 | 3 |
| 2012 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 2 | 2 | 4 |
| 2015 | 1 | 0 | 1 |
| 2016 | 0 | 2 | 2 |
| 2017 | 1 | 0 | 1 |
| 2020 | 0 | 3 | 3 |
| 2021 | 0 | 2 | 2 |
| 2024 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hemagglutinin Glycoproteins, Influenza Virus" by people in Profiles.
-
Measures of Population Immunity Can Predict the Dominant Clade of Influenza A (H3N2) in the 2017-2018 Season and Reveal Age-Associated Differences in Susceptibility and Antibody-Binding Specificity. Influenza Other Respir Viruses. 2024 Nov; 18(11):e70033.
-
High-throughput sequencing-based neutralization assay reveals how repeated vaccinations impact titers to recent human H1N1 influenza strains. J Virol. 2024 Oct 22; 98(10):e0068924.
-
Librator: a platform for the optimized analysis, design, and expression of mutable influenza viral antigens. Brief Bioinform. 2022 03 10; 23(2).
-
Teach 'em young: Influenza vaccines induce broadly neutralizing antibodies in children. Cell Rep Med. 2022 02 15; 3(2):100531.
-
Broadly neutralizing antibodies target a haemagglutinin anchor epitope. Nature. 2022 02; 602(7896):314-320.
-
Functionality of the putative surface glycoproteins of the Wuhan spiny eel influenza virus. Nat Commun. 2021 10 25; 12(1):6161.
-
An Egg-Derived Sulfated N-Acetyllactosamine Glycan Is an Antigenic Decoy of Influenza Virus Vaccines. mBio. 2021 06 29; 12(3):e0083821.
-
First exposure to the pandemic H1N1 virus induced broadly neutralizing antibodies targeting hemagglutinin head epitopes. Sci Transl Med. 2021 06 02; 13(596).
-
Influenza hemagglutinin-specific IgA Fc-effector functionality is restricted to stalk epitopes. Proc Natl Acad Sci U S A. 2021 02 23; 118(8).
-
Modeling human adaptive immune responses with tonsil organoids. Nat Med. 2021 01; 27(1):125-135.